5-fluorouracil degradation rate (5-FU-DR) as a new toxicity predictive biomarker for adjuvant FOLFOX in colorectal cancer (CRC) patients

Authors :: Mario Occhipinti
F.R. Di Pietro
Adriana Romiti
Federica Mazzuca
Rosa Falcone
A. Botticelli
Annalisa Milano
Luana Lionetto
Piero Marchetti
Michela Roberto
Maurizio Simmaco
Concetta Elisa Onesti
Source :: Annals of Oncology. 27:vi195
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oncology
medicine.medical_specialty
Colorectal cancer
business.industry
medicine.medical_treatment
Hematology
medicine.disease
FOLFOX
Fluorouracil
Internal medicine
Toxicity
medicine
business
Adjuvant
medicine.drug
Predictive biomarker

Full Text Access

Tools